Compounds > alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
Page last updated: 2024-10-21

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Autosomal Dominant Juvenile Parkinson Disease

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Autosomal Dominant Juvenile Parkinson Disease in 1 studies

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Parker, PR1
Lalive, AL1
Kreitzer, AC1

Other Studies

1 other study available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Autosomal Dominant Juvenile Parkinson Disease

ArticleYear
Pathway-Specific Remodeling of Thalamostriatal Synapses in Parkinsonian Mice.
    Neuron, 2016, Feb-17, Volume: 89, Issue:4

    Topics: Adrenergic Agents; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Corpus Striatu

2016